Insights on the Reiter's Syndrome Treatment Global Market to 2027 - Rapidly Increasing Reactive Arthritis Incidences and Rising Demand for Effective Treatment are Expected to Drive Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Reiter's Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Drug Type, Immunosuppressive Drugs, Others, By Dosage Form, By Route of Administration, By Distribution Channel, By End User, By Region" report has been added to ResearchAndMarkets.com's offering.

The global Reiter's syndrome treatment market is anticipated to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the rising instances of reactive arthritis and advancements in treatment processes and methods.

Besides, advances in the healthcare industry have led to better accessibility of patient care suffering from severe conditions like reactive arthritis, contributing to the growth of the global Reiter's syndrome treatment market.

Reiter's syndrome is a type of inflammatory arthritis, which is also known as reactive arthritis. The painful inflammation is caused by a bacterial infection. These bacteria are frequently found in the genital tract, such as Chlamydia trachomatis, or the bowel, such as Campylobacter, Salmonella, Shigella, and Yersinia. Genital bacteria spread through sex and usually causes no noticeable symptoms. A pus-like or watery discharge from the genitals is observed in some cases. Bowel bacteria, on the other hand, usually cause diarrhea along with discharge and can be considered minor symptom of Reiter's syndrome.

Rapidly increasing reactive arthritis incidences and rising demand for effective treatment are expected to drive the global Reiter's syndrome treatment market over the next five years. When compared to other types of arthritis, reactive arthritis is a rare form. As of 2021, more than 350 million arthritis patients are affected by Reiter's syndrome. According to the CDC, arthritis affects 24% of all adults in the United States, approx. 58.5 million people. One in every four adults has arthritis and suffers from severe joint pain.

Reiter's syndrome affects approximately 27 per 100,000 people worldwide, with adult males aged 20 to 40 most affected. Growing population, rising instances of unprotected sexual intercourse increase the population's chances of contracting the disease and assist in the growth of the global Reiter's syndrome treatment market over the next five years.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023-2027

Objective of the Study:

• To analyze the historical growth in the market size of the global Reiter's syndrome treatment from 2017 to 2023.
• To estimate and forecast the market size of global Reiter's syndrome treatment market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the global Reiter's syndrome treatment market based on drug type, dosage form, route of administration, distribution channel, end user, region, and company.
• To identify the dominant region or segment in the global Reiter's syndrome treatment market.
• To identify drivers and challenges for the global Reiter's syndrome treatment market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global Reiter's syndrome treatment market.
• To identify and analyze the profiles of leading players operating in the global Reiter's syndrome treatment market.
• To identify key sustainable strategies adopted by market players in global Reiter's syndrome treatment market.

Companies Mentioned

• F. Hoffmann-La Roche AG
• Pfizer, Inc.
• Novartis AG
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.
• Abbott Laboratories, Inc.
• GlaxoSmithKline plc
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries Ltd
• AstraZeneca, Plc.

Report Scope:

In this report, global Reiter's syndrome treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Reiter's Syndrome Treatment Market, By Drug Type:

• Antibiotics
• Corticosteroids
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Immunosuppressive Drugs
• Others

Reiter's Syndrome Treatment Market, By Dosage Form:

• Tablets
• Injections
• Others

Reiter's Syndrome Treatment Market, By Route of Administration:

• Oral
• Intravenous
• Others

Reiter's Syndrome Treatment Market, By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Reiter's Syndrome Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Reiter's Syndrome Treatment Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• South America
• Brazil
• Argentina
• Colombia

For more information about this report visit https://www.researchandmarkets.com/r/50fi2l